Omada Health (NASDAQ: OMDA) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $873M. The Maz Rating grades it against the other companies in its sector.
Omada Health's current Maz Rating and its five factor grades are for members: log in to see them.
At $14.08, Omada Health trades at 59.2x trailing earnings, 2.6x sales and 3.2x book value, with an EV/EBITDA of 39.9. Over the last twelve months it generated about $333M of revenue and $15M of net income. It runs a gross margin of 70.7%, an operating margin of 2.1% and a net margin of 4.2%. It shows return on equity of 5.7%, return on invested capital of 2.5% and a free cash flow yield of 2.9%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 4.18. Over the past 52 weeks the share price ranged from $10.28 to $25.45, with a beta of 2.12.
Omada Health does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 11 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.